September 28 2006 Issue Medical Staff Pulse is
a Publication of the Chief of Staff

Institute Performs Research on all Types of Stem Cells

With the recent opening of its new International Stem Cell Research Institute, Cedars-Sinai has begun conducting both adult and embryonic stem cell research for the first time.

2007 Quality Goals

The Medical Executive Committee has announced the following six medical staff quality goals for fiscal year 2007.

Multi-Drug Resistant Organism Potential Outbreak - Acinetobacter baumanii

Across the nation, as well as here at Cedars-Sinai, Acinetobacter baumanii has emerged as a highly resistant gram-negative organism responsible for nosocomial infections. It is seen mainly in patients who are ventilator dependent and patients with multiple co-morbidities.

New Medication May Add to Patients' Fall Risk

Ropinirole (Requip�), a new medication on formulary that is used to reduce symptoms of Parkinson's disease


Physicians Asked to Encourage SBAR Use

GETTING JUICED ABOUT SBAR: Chief of Staff Paul Silka, M.D., hands out free juice smoothies to physicians at a special "Welcome to the SBAR Juice Bar" event on August 29 to help familiarize medical staff with the SBAR communication model.

The Wall Street Journal* calls it the Bermuda Triangle of health care, where valuable patient information can mysteriously disappear.

New Simulation Lab Aids in Training 
Procedure offers key advantages to physicians

George Berci, M.D. honored at American College of Surgeons meeting

Glenn Braunstein, M.D. received Endocrine Society Physician Award

Joel Geiderman, M.D. is appointed to Holocaust Oversight Committee

Andrew Klein, M.D. receives Endowed Chair in Surgery and Transplant

Mark Noah, M.D. receives Endowed Chair in Medical Education

Barry Pressman, M.D. is appointed to Medicare Advisory Committee

Michael Waters, M.D. is honored with Founders Award


Steven A. Feig, M.D.

Calling it his quest for immortality, pediatrician Steven Feig enjoys spinning his wheels. A longtime bicycling enthusiast, he follows a rigorous fitness program.

Potential Prostate Cancer Treatment Improvements

Research found that Raloxifene, a drug used for osteoporosis, has potential benefit for treating men with prostate cancer

Prostate Cancer Patients Sought for Database

Researchers hope data will lead to future treatments

MEC Meeting Change: Tuesday, Nov. 7

A Night at the Theater: Wednesday, Nov. 8, 2006

Road to a Cure Gala: Thursday, Nov. 16

A Night at the Copa: Sunday, Nov. 19

Share Your Story

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest by clicking on the link below to e-mail the Chief of Staff's office.

E-mail Chief of Staff's Office